Health of children born as a result of in vitro fertilization

Health Services Research, National Research and Development Centre for Welfare and Health, Helsinki, Finland.
PEDIATRICS (Impact Factor: 5.3). 12/2006; 118(5):1819-27. DOI: 10.1542/peds.2006-0735
Source: PubMed

ABSTRACT The purpose of this study was to use nationwide registries to examine the health of children up to 4 years of age who were born as a result of in vitro fertilization.
Children born after in vitro fertilization (N = 4559) from 1996 to 1999 were monitored until 2003. Two control groups were selected from the Finnish Medical Birth Register as follows: all other children (excluding children born after ovulation induction) from the same period (N = 190,398, for study of perinatal health and hospitalizations) and a random sample of those children (n = 26,877, for study of health-related benefits). Mortality rates and odds ratios for perinatal outcomes, hospitalizations, health-related benefits, and long-term medication use were calculated.
Although the health of most in vitro fertilization children was good, such children had more health problems than other children. A total of 35.7% of in vitro fertilization children and 2.2% of control children were multiple births, and the health of multiple births was worse than that of singletons. Perinatal outcomes of in vitro fertilization children were worse and hospital episodes were more common than among control children. Risks for cerebral palsy and psychological and developmental disorders were increased. Among in vitro fertilization singletons, worse results for perinatal outcomes and hospitalizations, but no increased risk for specific diseases, were found. The health of in vitro fertilization multiple births was comparable to the health of control multiple births.
Reducing the number of transferred embryos would improve the health of in vitro fertilization children. Additional studies are needed to explain the poorer health of in vitro fertilization singletons, as well as follow-up studies to examine the health of in vitro fertilization children from 4 years onward.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: As the interface between the mother and the developing fetus, the placenta is believed to play an important role in assisted reproductive technology (ART)-induced aberrant intrauterine and postnatal development. However, the mechanisms underlying aberrant placentation remain unclear, especially during the extra-embryonic tissue development and early stage of placental formation. Using a mouse model, this investigation provides the first comparative proteomic analysis of in vivo (IVO) and in vitro produced (IVP) extra-embryonic tissues and placentas after in vivo fertilization and development, or in vitro fertilization and culture, respectively. We identified 165 and 178 differentially expressed proteins (DEPs) between IVO and IVP extra-embryonic tissues and placentas on Embryonic Day 7.5 (E7.5) and E10.5, respectively. Many DEPs were functionally associated with genetic information processing, such as impaired de novo DNA methylation, as well as post-transcriptional, translational and post-translational dysregulation. These novel findings were further confirmed by global hypomethylation, and a lower level of correlation was found between the transcriptome and proteome in the IVP groups. In addition, numerous DEPs were involved in energy and amino acid metabolism, cytoskeleton organization and transport, and vasculogenesis and angiogenesis. These disturbed processes and pathways are likely to be associated with embryonic intrauterine growth restriction, an enlarged placenta and impaired labyrinth morphogenesis. This study provides a direct and comprehensive reference for the further exploration of the placental mechanisms that underlie ART-induced developmental aberrations.
    Biology of Reproduction 10/2014; DOI:10.1095/biolreprod.114.124248 · 3.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we explored the relationship between the rise in the incidence of autism spectrum disorder (ASD), the rise in the use of assisted reproductive technology (ART), and the role of infertility. We compared the incidence of ASD in children conceived with and without the use of ART. We also considered the incidence of ASD in children whose parents reported issues of infertility. Ninety families completed a confidential questionnaire and reported use of ART, ASD diagnoses of their children, infertility, parent age at time of conception, socioeconomic status, and other variables. We obtained information for a total of 163 children. Findings indicate that there is not a significant difference in the incidence of ASD diagnoses among participants who used ART compared to those that did not. Additionally, infertility was not found to be associated with increased rates of ASD diagnoses. Limitations include small sample sizes and reliance on parent report. Implications are discussed.
    Research in Autism Spectrum Disorders 10/2014; 9. DOI:10.1016/j.rasd.2014.10.009 · 2.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With an ever-expanding population of children born after in-vitro fertilisation (IVF), the widespread use of assisted reproductive techniques (ART) has placed a great emphasis on the need to study their long-term outcomes. Indeed, there has been concern that mechanisms used in ART may have a detrimental effect on the neurocognitive development of these children. Reassuringly, most neurocognitive and motor development studies using various assessment scales have generally found no differences between intracytoplasmic sperm injection, IVF and naturally conceived children. Only a few studies have reported concerns. In terms of predictors of intelligence in children, ART appears to have a minimal effect in comparison to birth weight, gestational age, socio-economic status, and parental educational levels. Nevertheless, further research of higher methodological quality in children beyond pre-school age and on newer ART procedures is needed.
    Seminars in Fetal and Neonatal Medicine 06/2014; DOI:10.1016/j.siny.2014.04.003 · 3.13 Impact Factor

Full-text (3 Sources)

Available from
Jan 8, 2015